Long-term garlic or micronutrient supplementation, but not anti-Helicobacter pylori therapy, increases serum folate or glutathione without affecting serum vitamin B-12or homocysteineina rural Chinese population

Journal of Nutrition

Volumn 139, Issue 1, 2009, Pages 106-112

  Wang, Yujue ^a   Zhang, Lian ^a   Moslehi, Roxana ^b   Ma, Junling ^a   Pan, Kaifeng ^a   Zhou, Tong ^a   Liu, Weidong ^c   Brown, Linda Morris ^b   Hu, Yuangreng ^d   Pee, David ^e   Gail, Mitchell H ^b   You, Weicheng ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^b NATIONAL CANCER INSTITUTE   (United States)

^c Linqu Public Health Bureau   (China)

^d WESTAT   (United States)

^e INFORMATION MANAGEMENT SERVICES INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; AMOXICILLIN; ASCORBIC ACID; CYANOCOBALAMIN; FOLIC ACID; GARLIC EXTRACT; GARLIC OIL; GLUTATHIONE; HOMOCYSTEINE; OMEPRAZOLE; SELENIUM; TRACE ELEMENT;

ADULT; ANTIMICROBIAL THERAPY; ARTICLE; CHINESE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; FEMALE; FOLIC ACID BLOOD LEVEL; HELICOBACTER INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRECANCER; RANDOMIZED CONTROLLED TRIAL; RURAL POPULATION; STOMACH LESION; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ADULT; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLIC ACID; GARLIC; GLUTATHIONE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HOMOCYSTEINE; HUMANS; MALE; MICRONUTRIENTS; MIDDLE AGED; OMEPRAZOLE; RURAL POPULATION; VITAMIN B 12;

ALLIUM SATIVUM; HELICOBACTER PYLORI;

EID: 58649124087     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.108.091389     Document Type: Article

References (47)

1. Gaytan RJ, Prisant LM. Oral nutritional supplements and heart disease: a review. Am J Ther. 2001;8:255-74.
2. Herrmann W. Significance of hyperhomocysteinemia. Clin Lab. 2006;52: 367-74.
3. Wu LL, Wu JT. Hyperhomocysteinemia is a risk factor for cancer and a new tumor marker. Clin Chim Acta. 2002;322:21-8.
4. Reynolds E. Vitamin B12, folic acid, and the nervous system. Lancet Neurol. 2006;5:949-60.
5. Fisher M, Lees K, Spence JD. Nutrition and stroke prevention. Stroke. 2006;37:2430-5.
6. Rampersaud GC, Bailey LB, Kauwell GPA. Relationship of folate to colorectal and cervical cancer: review and recommendations for practitioners. J Am Diet Assoc. 2002;102:1273-82.
7. Shimizu H, Kiyohara Y, Kato I, Kitazono T, Tanizaki Y, Kubo M, Ueno H, Ibayashi S, Fujishima M, et al. Relationship between plasma glutathione levels and cardiovascular disease in a defined population: the Hisayama study. Stroke. 2004;35:2072-7.
8. Nuttall SL, Martin U, Sinclair AJ, Kendall MJ. Glutathione: in sickness and in health. Lancet. 1998;351:645-6.
9. Beutler E, Gelbart T. Plasma glutathione in health and in patients with malignant disease. J Lab Clin Med. 1985;105:581-4.
10. Richie JP Jr. The role of glutathione in aging and cancer. Exp Gerontol. 1992;27:615-26.
11. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact. 2006;160:1-40.
12. Locigno R, Castronovo V. Reduced glutathione system: role in cancer development, prevention and treatment. (review) Int J Oncol. 2001;19: 221-36.
13. Hankey GJ. Is plasma homocysteine a modifiable risk factor for stroke? Nat Clin Pract Neurol. 2006;2:26-33.
14. Cook S, Hess OM. Homocysteine and B vitamins. Handb Exp Pharmacol. 2005;170:325-38.
15. Verhoef P, Stampfer M, Buring JE, Gaziano JM, Allen RH, Stabler SP, Reynolds RD, Kok FJ, Hennekens CH, et al. Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate. Am J Epidemiol. 1996;143:845-59.
16. Ramakrishnan S, Sulochana KN, Lakshmi S, Selvi R, Anqayarkanni N. Biochemistry of homocysteine in health and diseases. Indian J Biochem Biophys. 2006;43:275-83.
17. Thompson J. Vitamins and minerals 4: overview of folate and the B vitamins. Community Pract. 2006;79:197-8.
18. Lim U, Wang SS, Hartge P, Cozen W, Kelemen LE, Chanock S, Davis S, Blair A, Schenk M, et al. Gene-nutrient interactions among determinants of folate and one-carbon metabolism on the risk of non-Hodgkin lymphoma: NCI-SEER case-control study. Blood. 2007;109:3050-9.
19. Mayes PA, Bender DA. The pentose phosphate pathway and other pathways of hexose metabolism. In: Murray RK, editor. Harpers illustrated biochemistry. San Francisco (CA): McGraw-Hill Companies, Inc. 2003. p.163-73.
20. Bradford GS, Taylor CT. Omeprazole and vitamin B12 deficiency. Ann Pharmacother. 1999;33:641-3.
21. Tamura A, Fujioka T, Nasu M. Relation of Helicobacter pylori infection to plasma vitamin B12, folic acid, and homocysteine levels in patients who underwent diagnostic coronary arteriography. Am J Gastroenterol. 2002;97:861-6.
22. Sipponen P, Laxe'n F, Huotari K, Harkonen M. Prevalence of low vitamin B12 and high homocysteine in serum in an elderly nale population: association with atrophic gastritis and Helicobacter pylori infection. Scand J Gastroenterol. 2003;38:1209-16.
23. Serin E, Gümürdül̈ Y, Özer B, Kayaselcuk F, Yilmaz U, Kocak R. Impact of Helicobacter pylori on the development of vitamin B12 deficiency in the absence of gastric atrophy. Helicobacter. 2002;7:337-41.
24. You WC, Blot WJ, Chang YS, Ershow A, Yang ZT, An Q, Henderson BE, Fraumeni JF, Wang T. Allium vegetables and reduced risk of stomach cancer. J Natl Cancer Inst. 1989;81:162-4.
25. You WC, Blot WJ, Chang YS, Ershow AG, Yang ZT, An Q, Henderson B, Xu GW, Fraumeni JF Jr, et al. Diet and high risk of stomach cancer in Shandong, China. Cancer Res. 1988;48:3518-23.
26. Zhang L, Blot WJ, You WC, Chang YS, Liu XQ, Kneller RW, Zhao L, Liu WD, Li JY, et al. Serum micronutrients in relation to pre-cancerous gastric lesions. Int J Cancer. 1994;56:650-4.
27. Gail MH, You WC, Chang YS, Zhang L, Blot WJ, Brown L, Li JY, Mark S, Liu WD, et al. Factorial trial of three interventions to reduce the progression of precancerous gastric lesions in Shandong China: design issues and initial data. Control Clin Trials. 1998;19:352-69.
28. You WC, Brown LM, Zhang L, Li JY, Jin ML, Chang YS, Ma JL, Pan KF, Liu WD, et al. Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. J Natl Cancer Inst. 2006;98:974-83.
29. Zhang L, Gail MH, Wang YQ, Brown LM, Pan KF, Ma JL, Amagase H, You WC, Moslehi R. A randomized factorial study of the effects of long-term garlic and micronutrient supplementation and of 2-wk antibiotic treatment for Helicobacter pylori infection on serum cholesterol and lipoproteins. Am J Clin Nutr. 2006;84:912-9.
30. Blot WJ, Li JY, Taylor PR, Guo W, Dawsey SM, Wang GQ, Yang CS, Zheng SF, Gail M, et al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst. 1993;85:1483-92.
31. You WC, Zhang L, Heinrich J, Ma JL, Chang YS, Liu WD, Brown L, Mark S, Yang CS, et al. An intervention trial to inhibit the progressionf precancerous gastric lesions: compliance, serum micronutrients and S-allyl cysteine levels, and toxicity. Eur J Cancer Prev. 2001;10:257-63.
32. Zhloba AA, Blashko EL. Liquid chromatographic determination of total homocysteine in blood plasma with photometric detection. J Chromatogr B. 2004;800:275-80.
33. Proc Robustreg. Available from: http://post.queensu.ca:8080/SASDoc/ getDoc/en/statug.hlp/rreg-sect6.htm.
34. 12, pantothenic acid, biotin, choline. Washington, DC: National Academy Press; 1998.
35. Gail MH, Pfeiffer RM, Brown LM, Zhang L, Ma JL, Pan KF, Liu WD, You WC. Garlic, vitamin, and antibiotic treatment for Helicobacter pylori: a randomized factorial controlled trial. Helicobacter. 2007;12:575-8.
36. Cafolla A, Dragoni F, Girelli G, Tosti ME, Costante A, De Luca AM, Funaro D, Scott CS. Effect of folic acid and vitamin C supplementation on folate status and homocysteine level: a randomized controlled trial in Italian smoker blood donors. Atherosclerosis. 2002;163:105-11.
37. Yeh YY, Yeh SM. Significance of garlic and its constituents in cancer and cardiovascular disease. J Nutr. 2006;136:S745-9.
38. Yeh Y, Yeh S, Lim HS, Picciano MF. Garlic extract reduces plasma concentrations of homocysteine in rats rendered folic acid deficiency. FASEB J. 1999;13:209-12.
39. McCrindle BW, Helden E, Conner WT. Garlic extract therapy in children with hypercholesterolemia. Arch Pediatr Adolesc Med. 1998;152:1089-94.
40. El-Bayoumy K, Richie JP, Boyiri T, Komninou D, Prokopczyk B, Trushin N, Kleinman W, Cox J, Pittman B, et al. Influence of selenium- enriched yeast supplementation on biomarkers of oxidative damage and hormone status in healthy adult males: a clinical pilot study. Cancer Epidemiol Biomarkers Prev. 2002;11:1459-65.
41. Hu JJ, Roush GC, Berwick M, Dubin N, Mahabir S, Chandiramani M, Boorstein R. Effects of dietary supplementation of alpha-tocopherol on plasma glutathione and DNA repair activities. Cancer Epidemiol Biomarkers Prev. 1996;5:263-70.
42. Jain SK, McVie R, Smith T. Vitamin E supplementation restores glutathione and malondialdehyde to normal concentrations in erythrocytes of type 1 diabetic children. Diabetes Care. 2000;23:1389-94.
43. Costagliola C, Libondi T, Menzione M, Rinaldi E, Auricchio G. Vitamin E and red blood cell glutathione. Metabolism. 1985;34:712-4.
44. Santhosh Kumar M, Selvam R. Supplementation of vitamin E and selenium prevents hyperoxaluria in experimental urolithic rats. J Nutr Biochem. 2003;14:306-13.
45. Puskas F, Gergely P, Banki K, Perl A. Stimulation of the pentose phosphate pathway and glutathione levels by dehydroascorbate, the oxidized form of vitamin C. FASEB 2000;14:1352-61.
46. Saltzman JR, Kemp JA, Golner BB, Pedrosa MC, Dallal GE, Russell RM. Effect of hypochlorhydria due to omeprazole treatment or atrophic gastritis on protein-bound vitamin B12 absorption. J Am Coll Nutr. 1994;13:584-91.
47. Swain R. An update on Vitamin B12 metabolism and deficiency status. J Fam Pract. 1995;41:595-600.